Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Acq. announced
CC transcript
Inv. presentation

SALIX PHARMACEUTICALS LTD (SLXP) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/01/2015 8-K Form 8-K - Current report
04/01/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
04/01/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/25/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/25/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/20/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/18/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/17/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/17/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/16/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/16/2015 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ¨ Written communications pursuant to Rule 425 under the Securities Act ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ¨ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ¨ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) Item 1.01. Entry into a Material Definitive Agreement. On March 16, 2015, Salix Pharmaceuticals, Ltd., a Delaware corporation , Valeant Pharmaceuticals International, Inc., a British Columbia corporation , Valeant Pharmaceuticals International, a Delaware corporation and a wholly-owned su...",
"Amendment No. 1 to the Agreement and Plan of Merger, among Valeant Pharmaceuticals International, Inc., Valeant Pharmaceuticals International, Sun Merger Sub, Inc. and Salix Pharmaceuticals, Ltd",
"VALEANT AND SALIX AGREE ON AMENDED TERMS TO MERGER AGREEMENT"
03/16/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/13/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/12/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/12/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/09/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/09/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/06/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/06/2015 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
03/04/2015 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
03/02/2015 10-K Annual Report for the period ended December 31, 2014
03/02/2015 8-K Quarterly results
Docs: "FORM 8-K",
"Salix Pharmaceuticals Reports 4Q2014 and FY2014 Results"
03/02/2015 10-Q/A Quarterly Report for the period ended September 30, 2014 [amend]
03/02/2015 10-Q/A Quarterly Report for the period ended June 30, 2014 [amend]
03/02/2015 10-Q/A Quarterly Report for the period ended March 31, 2014 [amend]
03/02/2015 10-K/A Annual Report for the period ended December 31, 2013 [amend]
02/27/2015 8-K Other Events
Docs: "Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ¨ Written communications pursuant to Rule 425 under the Securities Act ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ¨ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ¨ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) Item 8.01 Other Events."
02/25/2015 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
02/24/2015 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
02/23/2015 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
02/23/2015 8-K Other Events
Docs: "FORM 8-K"
02/23/2015 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
02/23/2015 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
02/23/2015 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy